Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
BIO
-0.09%
▼ -1.24%
GMED
5.94%
▼ -21.10%
Gross Margin
BIO
53.12%
▲ 0.86%
GMED
69.42%
▲ 0.23%
Free Cash Flow
BIO
$66.70M
▼ -$11.40M
GMED
$176.57M
▲ $13.82M
Net Debt / EBITDA
BIO
-0.78
▼ -0.38
GMED
-0.55
▲ 0.03
Operating Margin
BIO
11.15%
▲ 5.39%
GMED
23.10%
▲ 1.58%
P/E Ratio
BIO
40.03
▼ -4.70
GMED
—